Cell signaling pathways and HIV-1 therapeutics

Johnny J. He

Research output: Contribution to journalReview articlepeer-review


Host-virus interactions permeate every aspect of both virus life cycle and host response and involve host cell macromolecular machinery and viral elements. It is these intimate interactions that mandate the outcomes of the infection and pathogenesis. It is also these intimate interactions that lay the foundation for the development of pharmaceutical interventions. HIV-1 is no exception in these regards. In the first two decades, HIV/AIDS research has led to the successful development of a number of antiviral inhibitors and the landmark formulation of the suppressive therapy. It has become apparent that this therapy does not offer a complete solution to cure and eradicate the virus. Meanwhile, this therapy has changed the overall landscape of HIV-associated neurological disorders to a more common and prevalent form so-called minor cognitive motor disorder. Thus, there is an important and continued need for new anti-HIV therapeutics. We believe that this is an excellent opportunity to compile and present the latest works being done during the last few years in this exciting field of HIV-host interactions, particularly cell signaling pathways. We hope that this special issue composed of one brief report, eight thematic reviews, and two original articles will serve to foster the exchange of new scientific ideas on HIV-host interactions and anti-HIV therapy and eventually contribute to HIV/AIDS eradication.

Original languageEnglish
Pages (from-to)173-176
Number of pages4
JournalJournal of Neuroimmune Pharmacology
Issue number2
StatePublished - Jun 2011


  • Anti-HIV therapeutics
  • Cell signaling
  • Gene expression
  • HIV-1
  • HIV-host interaction
  • Replication


Dive into the research topics of 'Cell signaling pathways and HIV-1 therapeutics'. Together they form a unique fingerprint.

Cite this